Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy.
about
Genetics of psoriasis and pharmacogenetics of biological drugsEnthesopathies and enthesitis. Part 1. EtiopathogenesisBiomarkers of An Autoimmune Skin Disease--PsoriasisUstekinumab for the treatment of psoriatic arthritis: an updateClinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia.Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases.Urine metabolome profiling of immune-mediated inflammatory diseases.Steps in the management of psoriatic arthritis: a guide for clinicians.Predictors of biologic treatment of psoriasis: a non-interventional studyTherapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.Pharmacogenetics of topical and systemic treatment of psoriasis.Investigational drugs for treating psoriatic arthritis.Factors affecting response to biologic treatment in psoriasis.Efficacy and safety of emerging immunotherapies in psoriasis.New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis.Pharmacogenomics of multifactorial diseases: a focus on psoriatic arthritis.Targeted therapies: what they teach us about the pathogenesis of psoriasis and psoriatic arthritis.Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics.Psoriasis and susceptibility to other autoimmune diseases: an outline for the clinician.Familial aggregation of moderate to severe plaque psoriasis.An investigation of rheumatoid arthritis loci in patients with early-onset psoriasis validates association of the REL gene.HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study.Identification of loci associated with late-onset psoriasis using dense genotyping of immune-related regions.Association of TNF-α polymorphism with prediction of response to TNF blockers in spondyloarthritis and inflammatory bowel disease: a meta-analysis.Tacrolimus for the management of psoriasis: clinical utility and place in therapy.Current treatment options for psoriatic arthritis: spotlight on abatacept.Psoriasis
P2860
Q21284816-4705E0C5-2265-4C45-B6CD-8ADCC3265D7AQ26775441-CD0342C2-6FF4-4A2C-852F-EE7BB32C3986Q26781378-8B2AE13E-FC58-478E-97F2-3343426AFDB3Q34154247-20243824-650B-4D8D-B768-C6B3B7446B49Q34365853-A5C869FB-9FEE-44B2-BA73-F089BCF1F2B5Q34638892-0783D784-6150-4A4B-AD5D-91F1E0CBC08DQ36127459-7B46CB3E-6F13-4EC4-95C3-83CC031D569DQ36515480-E0EEE5CE-C7E5-451E-9873-FA507D0523C8Q37600690-8FB7EE67-A61C-4AD6-B16A-E4A5DE5D24B2Q38098466-030500E2-0A01-4F3B-9E9B-D3C683ADEB82Q38148599-2D67F2D8-79CA-4DE8-9023-CB293715B340Q38206551-9BBE16A3-2D28-4DCC-A7DF-B08E4D295DB2Q38232919-39DD83D4-DA74-4C3B-A918-42DDC6AF1855Q38365042-B577739F-249D-4F7C-B9D4-99BEDA023C85Q38799600-8B145801-2361-4348-BF0F-92C0F902E239Q38857254-216C3F65-E78F-43F5-B8F4-E17684BDBBAFQ38969036-563FFA3C-3F5A-4674-8513-FCC4E904112CQ41060904-8935B7A0-E21D-4679-ADC3-EE908EA4BED4Q44195758-A791133F-D616-4EDC-B8CB-6169CCD1FC1BQ44528603-9656B52A-DD85-4EA4-A5A5-054E46BA3A73Q45189996-E851F47C-4AF8-4286-9D40-FA5AE4363C74Q50927361-175B7F4D-724B-4B90-8B6A-F73C2300DF25Q51510464-E13685EA-C0F2-4014-B4C0-A8A37BE0CCB3Q54659621-1CBE79D9-81CD-4C12-BDD8-62BE1026B568Q55023453-66F945CE-A2A7-4CDC-976D-527E4CC8222BQ55318901-E7201B85-DF2D-4D8D-A4E8-98DF60DC12A3Q58235909-FC740D92-0418-4589-9B23-E1ED421D4BE5
P2860
Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy.
@en
Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy.
@nl
type
label
Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy.
@en
Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy.
@nl
prefLabel
Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy.
@en
Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy.
@nl
P2093
P2860
P50
P1476
Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy
@en
P2093
C E M Griffiths
H L Hébert
R B Warren
P2860
P304
P356
10.1111/J.1365-2133.2011.10712.X
P407
P577
2012-03-01T00:00:00Z